Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “The Board of Regents of the University of Texas System”

1,742 pharma patents match "The Board of Regents of the University of Texas System" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,742
Index total 30,257
Page 11 / 73

Quick answer

This filtered view shows 1,742 pharmaceutical patents matching "The Board of Regents of the University of Texas System" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,742 results for “The Board of Regents of the University of Texas System” · 30,257 patents in full index Clear search

  1. US 11642354

    Methods and compositions comprising ursolic acid and/or resveratrol for treating diabetes, or cancer

    The Board of Regents of the University of Texas System · Granted May 9, 2023 · Expires May 4, 2043

    granted
  2. US 11629122

    Linkers for antibody drug conjugates

    The Board of Regents of the University of Texas System · Granted Apr 18, 2023 · Expires Apr 13, 2043

    granted
  3. US 11612580

    Compositions for inhibiting 3′ repair exonuclease 2 and methods of screening for such compositions

    The Board of Regents of the University of Texas System · Granted Mar 28, 2023 · Expires Mar 23, 2043

    granted
  4. US 11602551

    Use of inosine for the treatment of t-reg deficiency

    The Board of Regents of the University of Texas System · Granted Mar 14, 2023 · Expires Mar 9, 2043

    granted
  5. US 11603365

    Salt forms and polymorphs of (r)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyridin-2-yl)acetamido) pyridazin-3-yl)-2-fluorobutyl)-n-methyl-1H-1,2,3-triazole-4-carboxamide

    The Board of Regents of the University of Texas System · Granted Mar 14, 2023 · Expires Mar 9, 2043

    granted
  6. US 11597707

    CGAS antagonist compounds

    The Board of Regents of the University of Texas System · Granted Mar 7, 2023 · Expires Mar 2, 2043

    granted
  7. US 11597916

    Nicotine degrading enzyme variants

    The Board of Regents of the University of Texas System · Granted Mar 7, 2023 · Expires Mar 2, 2043

    granted
  8. US 11597774

    Antibody variable domains and antibody constructs

    The Board of Regents of the University of Texas System · Granted Mar 7, 2023 · Expires Mar 2, 2043

    granted
  9. US 11590085

    Compositions and methods for organ specific delivery of nucleic acids

    The Board of Regents of the University of Texas System · Granted Feb 28, 2023 · Expires Feb 23, 2043

    granted
  10. US 11594135

    Methods of CD40 activation and immune checkpoint blockade

    The Board of Regents of the University of Texas System · Granted Feb 28, 2023 · Expires Feb 23, 2043

    granted
  11. US 11591319

    Small molecule inducers of autophagy

    The Board of Regents of the University of Texas System · Granted Feb 28, 2023 · Expires Feb 23, 2043

    granted
  12. US 11591579

    Human methylthioadenosine/adenosine depleting enzyme variants for cancer therapy

    The Board of Regents of the University of Texas System · Granted Feb 28, 2023 · Expires Feb 23, 2043

    granted
  13. US 11576883

    L-DOPA microbiome therapy

    The Board of Regents of the University of Texas System · Granted Feb 14, 2023 · Expires Feb 9, 2043

    granted
  14. US 11576889

    Methods of identifying and treating patients with HIF-2 inhibitor resistance

    The Board of Regents of the University of Texas System · Granted Feb 14, 2023 · Expires Feb 9, 2043

    granted
  15. US 11565027

    Hydrogel membrane for adhesion prevention

    The Board of Regents of the University of Texas System · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  16. US 11560366

    Bicyclo[1.1.1]pentane inhibitors of dual leucine zipper (DLK) kinase for the treatment of disease

    The Board of Regents of the University of Texas System · Granted Jan 24, 2023 · Expires Jan 19, 2043

    granted
  17. US 11548945

    T-cell receptor (TCR)-binding antibodies and uses thereof

    The Board of Regents of the University of Texas System · Granted Jan 10, 2023 · Expires Jan 5, 2043

    granted
  18. US 11542229

    Cationic sulfonamide amino lipids and amphiphilic zwitterionic amino lipids

    The Board of Regents of the University of Texas System · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted
  19. US 11542486

    Human kynureninase enzyme variants having improved pharmacological properties

    The Board of Regents of the University of Texas System · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted
  20. US 11534463

    Nucleic acids encoding kynurenine depleting enzymes

    The Board of Regents of the University of Texas System · Granted Dec 27, 2022 · Expires Dec 22, 2042

    granted
  21. US 11529314

    Lipid-based nanoparticles for encapsulation and sustained release of therapeutic agents

    The Board of Regents of the University of Texas System · Granted Dec 20, 2022 · Expires Dec 15, 2042

    granted
  22. US 11525002

    Human PD-L1 antibodies and methods of use therefor

    The Board of Regents of the University of Texas System · Granted Dec 13, 2022 · Expires Dec 8, 2042

    granted
  23. US 11517633

    Production of Lu-177 and other radionuclides via hot atom capture on nanostructured carbon

    The Board of Regents of the University of Texas System · Granted Dec 6, 2022 · Expires Dec 1, 2042

    granted
  24. US 11518800

    Mutations that drive VH4 antibody autoreactivity

    The Board of Regents of the University of Texas System · Granted Dec 6, 2022 · Expires Dec 1, 2042

    granted